FluroTech Ltd. (FLURF)
FluroTech Ltd. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Calgary, AB, CA. The stock last traded at $0.00, giving a market capitalisation of $447,175. On trailing twelve-month figures it carries a trailing P/E of -2.33, a net margin of 0.0%. Its beta of -0.44 implies it has historically moved less than the broad market.
FluroTech Ltd. operates as a technology and marketing firm, primarily focused on advancing and commercializing various innovations within the pandemic defense industry. The company is responsible for developing the FluroTest SARS-CoV-2 diagnostic, which is designed to pinpoint patients with active viral infections. Its headquarters are located in Calgary, Canada.
FluroTech Ltd. is most often compared with the following Healthcare names: